Insights provides context and perspective about key pharmacy trends and issues

Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars More
Briefing
Specialty
Advancing Our Clinical Agenda
Advancing Caremark’s clinical agenda through population health More
Commentary
Specialty
How Digital Connectivity Improves the Patient Experience
CVS Health leader discusses the value of being connected in care to patients and providers More
Briefing
Specialty
The Impact of Autoimmune Conditions on Women
Women are overrepresented among autoimmune patients so may benefit the most from new biosimilar treatments More
Briefing
Specialty
Member Education: How We Help Build Awareness
Supporting members through prescription changes with CVS Health’s many touchpoints, expertise, and data More
Briefing
Specialty
Specialty Dermatologicals Spend Grows 168 Percent in 5 Years
Specialty Dermatologicals Continue to Be High Cost Drivers More
Briefing
Specialty
The First Biosimilar to Humira Is Here. Now What?
The First Biosimilar to Humira Is Here More
Briefing
Female caregiver and elderly patient discussing medical information on a couch
Specialty
Safer Options for Infusion Treatments
Research published by Coram shows that helping patients transition to at-home or ambulatory center infusion treatments can be beneficial to both patients and payors. More
Briefing
Icon of an infusion bag, overlaying a rising line graph
Specialty
Managing the MS Cost Challenge
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment and needs... More
Briefing
Specialty
A Virtual Approach to Keep Specialty Costs Down
A Virtual Approach to Keep Specialty Costs Down More
Briefing